imatinib mesylate has been researched along with Abortion, Spontaneous in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bose, CK; Dasgupta, S; Gharami, F; Kanti Ray, U; Mukhopadhyay, A; Mukhopadhyay, S | 1 |
Ault, P; Beran, M; Cortes, J; Faderl, S; Giles, F; Kantarjian, H; Keating, M; Koller, C; O'Brien, S; Rios, MB; Talpaz, M | 1 |
Ali, R; Ozcelik, T; Ozkalemkas, F; Ozkan, A; Ozkocaman, V | 1 |
Apperley, JF; Ault, P; Cortes, J; Hatfield, A; Kantarjian, H; Pilot, R; Pye, SM; Rosti, G | 1 |
4 other study(ies) available for imatinib mesylate and Abortion, Spontaneous
Article | Year |
---|---|
Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrimidines; Young Adult | 2015 |
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Topics: Abortion, Spontaneous; Adult; Antineoplastic Agents; Benzamides; Congenital Abnormalities; Disease Progression; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Medical Records; Metaphase; Philadelphia Chromosome; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrimidines; Retrospective Studies; Teratogens | 2006 |
Imatinib and pregnancy.
Topics: Abortion, Spontaneous; Adult; Animals; Antineoplastic Agents; Benzamides; Congenital Abnormalities; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimesters; Protein-Tyrosine Kinases; Pyrimidines; Teratogens | 2006 |
The effects of imatinib on pregnancy outcome.
Topics: Abnormalities, Multiple; Abortion, Spontaneous; Antineoplastic Agents; Benzamides; Craniofacial Abnormalities; Female; Humans; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pyrimidines; Retrospective Studies; Risk Factors | 2008 |